The rising interest in GLP-1 agonists for diabetes has sparked a debate about formats: skin-applied devices versus tablets . Typically, GLP-1 treatments were exclusively available in tablet form, but the https://gerardutoz217670.mdkblog.com/47086341/glp-1-transdermal-delivery-systems-vs-pills-which-suitable-for-individuals